What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.41%Below 5Y avg (0.90%)
Annual Rate
CNY 0.18Paid annual
Payout Ratio
33.3%Sustainable
Last Ex-Dividend
Jun 17, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
7.04BCNY
1.05B · vs all stocks (USD)
Updated Sep 22, 2026
Trailing P/E
81.48x
vs Medical Devices peers
Updated Sep 22, 2026
Revenue (TTM)
781.87MCNY
116.71M · vs all stocks (USD)
Updated Sep 22, 2026
Profit Margin
10.54%
vs Medical Devices peers
Updated Sep 22, 2026
Beta
0.4230x
vs all stocks
Updated Sep 22, 2026
52-Week Change
-14.56%
vs all stocks
Updated Sep 22, 2026
Market Capitalization
7.04BCNY
1.05B · vs all stocks (USD)
Updated Sep 22, 2026
Enterprise Value
6.13BCNY
914.87M · vs all stocks (USD)
Updated Sep 22, 2026
Trailing P/E
81.48x
vs Medical Devices peers
Updated Sep 22, 2026
Forward P/E
52.48x
vs Medical Devices peers
Updated Sep 22, 2026
Price to Sales (TTM)
9.00x
vs Medical Devices peers
Updated Sep 22, 2026
Price to Book (MRQ)
3.27x
vs Medical Devices peers
Updated Sep 22, 2026
Enterprise to Revenue
7.84x
vs Medical Devices peers
Updated Sep 22, 2026
Enterprise to EBITDA
68.57x
vs Medical Devices peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 59.07×.Updated Sep 22, 2026
Gross Margin
67.02%
vs Medical Devices peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 64.99%.Updated Sep 22, 2026
Profit Margin
10.54%
vs Medical Devices peers
Updated Sep 22, 2026
Operating Margin
0.82%
vs Medical Devices peers
Updated Sep 22, 2026
Return on Assets (TTM)
0.72%
vs Medical Devices peers
Updated Sep 22, 2026
Return on Equity (TTM)
3.99%
vs Medical Devices peers
Updated Sep 22, 2026
Revenue (TTM)
781.87MCNY
116.71M · vs all stocks (USD)
Updated Sep 22, 2026
Revenue per Share (TTM)
5.13CNYUpdated Sep 22, 2026
Quarterly Revenue Growth
4.10%
vs Medical Devices peers
Updated Sep 22, 2026
Gross Profit (TTM)
508.12MCNY
75.85M · vs all stocks (USD)
Updated Sep 22, 2026
EBITDA (TTM)
103.76MCNY
15.49M · vs all stocks (USD)
Updated Sep 22, 2026
Net Income (TTM)
82.42MCNY
12.30M · vs all stocks (USD)
Updated Sep 22, 2026
Quarterly Earnings Growth (YoY)
15.20%
vs Medical Devices peers
Updated Sep 22, 2026
Operating Cash Flow (TTM)
180.56MCNY
26.95M · vs all stocks (USD)
Updated Sep 22, 2026
Levered Free Cash Flow (TTM)
-168.56MCNY
-25.16M · vs all stocks (USD)
Updated Sep 22, 2026
Trailing Annual Dividend Rate
0.1800CNYUpdated Sep 22, 2026
Trailing Annual Dividend Yield
0.41%
vs all stocks
Updated Sep 22, 2026
5-Year Average Dividend Yield
0.90%
vs all stocks
Updated Sep 22, 2026
Payout Ratio
33.33%
vs Medical Devices peers
Updated Sep 22, 2026
Minority Interest (Equity)
10.75MCNYFY2025 · Dec 31, 2025
Revenue
767.75MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
256.21MCNYFY2025 · Dec 31, 2025
Gross Profit
511.54MCNYFY2025 · Dec 31, 2025
Operating Income
65.88MCNY
9.83M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
74.43MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-1.56MCNYFY2025 · Dec 31, 2025
Net Income
75.99MCNYFY2025 · Dec 31, 2025
EBIT
80.13MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
146.77MCNYFY2025 · Dec 31, 2025
Research & Development
175.06MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
132.71MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
14.94MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
23.02MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
5.70MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.5100CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.5100CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
153.25MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
153.25MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
75.99MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
2.17MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
16.54MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-270.56MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
683.26MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
75.99MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
14.06MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
5.13MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-78.63MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-287.10MCNYFY2025 · Dec 31, 2025
Net Acquisitions
5.15MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-5.75MCNYFY2025 · Dec 31, 2025
Sale of Investments
923.88KCNYFY2025 · Dec 31, 2025
Other Investing Activity
-109.51MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-396.29MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
300.63MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-529.71MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-44.43MCNYFY2025 · Dec 31, 2025
Other Financing Charges
460.58MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
187.06MCNYFY2025 · Dec 31, 2025
Shares Outstanding
160.00MSharesUpdated Sep 22, 2026
Float Shares
50.75MSharesUpdated Sep 22, 2026
% Held by Insiders
68.03%
vs all stocks
Updated Sep 22, 2026
% Held by Institutions
2.77%
vs all stocks
Updated Sep 22, 2026
Total Cash (MRQ)
899.35MCNY
134.25M · vs all stocks (USD)
Updated Sep 22, 2026
Total Cash per Share (MRQ)
5.76CNYUpdated Sep 22, 2026
Total Debt (MRQ)
574.78MCNY
85.80M · vs all stocks (USD)
Updated Sep 22, 2026
Total Debt to Equity (MRQ)
0.2723x
vs Medical Devices peers
Updated Sep 22, 2026
Current Ratio (MRQ)
1.60x
vs Medical Devices peers
Updated Sep 22, 2026
Book Value per Share (MRQ)
13.46CNYUpdated Sep 22, 2026
Total Assets
3.27BCNY
487.77M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.49BCNYFY2025 · Dec 31, 2025
Total Liabilities
1.19BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.78BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
236.57MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
950.84MCNYFY2025 · Dec 31, 2025
Cash
702.05MCNYFY2025 · Dec 31, 2025
Cash Equivalents
20.40MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
722.46MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
52.00MCNYFY2025 · Dec 31, 2025
Accounts Receivable
60.00MCNYFY2025 · Dec 31, 2025
Inventory
304.20MCNYFY2025 · Dec 31, 2025
Accounts Payable
122.65MCNYFY2025 · Dec 31, 2025
Short-term Debt
486.65MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
24.13MCNYFY2025 · Dec 31, 2025
Long-term Debt
87.55MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
160.00MCNYFY2025 · Dec 31, 2025
Retained Earnings
717.22MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
2.08BCNY
310.53M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
201.83MCNYFY2025 · Dec 31, 2025
52-Week Low
36.42CNYUpdated Sep 22, 2026
52-Week High
95.00CNYUpdated Sep 22, 2026
52-Week Change
-14.56%
vs all stocks
Updated Sep 22, 2026
Beta
0.4230x
vs all stocks
Updated Sep 22, 2026
50-Day MA
42.50CNYUpdated Sep 22, 2026
200-Day MA
55.71CNYUpdated Sep 22, 2026
Avg 10-Day Volume
2.09MSharesUpdated Sep 22, 2026
Avg 30-Day Volume
1.98MSharesUpdated Sep 22, 2026
Diluted EPS (TTM)
0.5400CNYUpdated Sep 22, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Almost nothing is lost between its operating profit and its net income.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.